These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9081676)

  • 41. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE study.
    Longenecker JC; Klag MJ; Marcovina SM; Powe NR; Fink NE; Giaculli F; Coresh J;
    Circulation; 2002 Nov; 106(22):2812-8. PubMed ID: 12451008
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms.
    Contois JH; Nguyen RA; Albert AL
    Clin Chim Acta; 2020 Jun; 505():119-124. PubMed ID: 32113814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
    Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
    Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
    Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
    Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F
    Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Further characterization of the plasma lipoprotein(a) distribution.
    Craig W; Poulin S; Bostom A; Eaton C; Laurino J; Ledue T; Ritchie R
    J Clin Lab Anal; 1995; 9(6):392-6. PubMed ID: 8587008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.
    Palumbo B; Lupattelli G; Siepi D; Bianchi A; Anniboletti PF; Blandini V; Sinzinger H; Mannarino E; Palumbo R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):987-91. PubMed ID: 12635466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apo(a) phenotyping and long-term prognosis for coronary artery disease.
    Baños-González MA; Peña-Duque MA; Anglés-Cano E; Martinez-Rios MA; Bahena A; Valente-Acosta B; Cardoso-Saldaña G; Angulo-Ortíz J; de la Peña-Díaz A
    Clin Biochem; 2010 May; 43(7-8):640-4. PubMed ID: 20153741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden.
    Dahlén GH; Weinehall L; Stenlund H; Jansson JH; Hallmans G; Huhtasaari F; Wall S
    J Intern Med; 1998 Nov; 244(5):425-30. PubMed ID: 9845859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.
    Gaw A; Docherty G; Brown EA; Ford I
    Atherosclerosis; 1999 Apr; 143(2):445-50. PubMed ID: 10217375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction.
    Thøgersen AM; Söderberg S; Jansson JH; Dahlén G; Boman K; Nilsson TK; Lindahl B; Weinehall L; Stenlund H; Lundberg V; Johnson O; Ahrén B; Hallmans G
    Eur J Cardiovasc Prev Rehabil; 2004 Feb; 11(1):33-40. PubMed ID: 15167204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia: characterization of a new plasma fragment pattern.
    Gonbert S; Saint-Jore B; Giral P; Doucet C; Chapman J; Thillet J
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1353-8. PubMed ID: 11498465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fish intake, independent of apo(a) size, accounts for lower plasma lipoprotein(a) levels in Bantu fishermen of Tanzania: The Lugalawa Study.
    Marcovina SM; Kennedy H; Bittolo Bon G; Cazzolato G; Galli C; Casiglia E; Puato M; Pauletto P
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1250-6. PubMed ID: 10323776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
    Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J
    Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
    J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.